Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 1/2013

01.01.2013 | Symposium: Papers Presented at the Annual Meetings of the Knee Society

Voriconazole Is Delivered From Antifungal-Loaded Bone Cement

verfasst von: Ryan B. Miller, MD, Alex C. McLaren, MD, Christine Pauken, PhD, Henry D. Clarke, MD, Ryan McLemore, PhD

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Local delivery of antifungals is an important modality in managing orthopaedic fungal infection. Voriconazole is a powder antifungal suitable for addition to bone cement that is released from bone cement but the mechanical properties of antimicrobial-loaded bone cement (ALBC) made with voriconazole are unknown.

Questions/Purposes

(1) Is voriconazole release dose-dependent? (2) Is released voriconazole active? (3) Is the loss of ALBC’s compressive strength caused by voriconazole dose- and elution-dependent?

Methods

Sixty standard test cylinders were fabricated with ALBC: 300 or 600 mg voriconazole per batch eluted for 30 days in deionized water. Voriconizole concentration in the eluate was measured using high-performance liquid chromatography. Cumulative-released voriconizole was calculated. Biologic activity was tested. Compressive strength was measured before and after elution. The effect of dose and time on release and compressive strength were analyzed using repeated-measure analysis of variance.

Results

Fifty-seven percent and 63% of the loaded voriconazole were released by Day 30 for the 300-mg and 600-mg formulations, respectively. The released voriconazole was active on bioassay. Compressive strength was reduced from 79 MPa to 53 MPa and 69 MPa to 31 MPa by 30 days for the 300-mg and 600-mg formulations, respectively.

Conclusions

Voriconazole release from ALBC increases with dose and is bioactive. Loss in compressive strength is greater after elution and with higher dose.

Clinical Relevance

Three hundred milligrams of voriconazole in ALBC would be expected to deliver meaningful amounts of active drug in vivo. The compressive strength of ALBC with 600 mg voriconazole is less than expected compared to commonly used antibacterials.
Literatur
1.
Zurück zum Zitat Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183:5385–5394.PubMedCrossRef Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183:5385–5394.PubMedCrossRef
2.
Zurück zum Zitat Cunningham B, McLaren A, Pauken C, McLemore R. Liposomal formulation increases local delivery of amphotericin from bone cement. Clin Orthop Relat Res. 2012 Mar 31 [Epub ahead of print]. DOI: 10.1007/s11999-012-2317-4. Cunningham B, McLaren A, Pauken C, McLemore R. Liposomal formulation increases local delivery of amphotericin from bone cement. Clin Orthop Relat Res. 2012 Mar 31 [Epub ahead of print]. DOI: 10.​1007/​s11999-012-2317-4.
3.
Zurück zum Zitat Diefenbeck M, Mückley T, Hofmann GO. Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury. 2006;37(Suppl 1):S95–S104.PubMedCrossRef Diefenbeck M, Mückley T, Hofmann GO. Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury. 2006;37(Suppl 1):S95–S104.PubMedCrossRef
4.
Zurück zum Zitat Eiden C, Mathieu O, Peyrière H, Hillaire-Buys D, Cociglio M. Simultaneous quantification of voriconazole and its N-oxide metabolite in human plasma by an easy and rapid isocratic LC nethod with UV detection. Chroma. 2008;67:275–280.CrossRef Eiden C, Mathieu O, Peyrière H, Hillaire-Buys D, Cociglio M. Simultaneous quantification of voriconazole and its N-oxide metabolite in human plasma by an easy and rapid isocratic LC nethod with UV detection. Chroma. 2008;67:275–280.CrossRef
5.
Zurück zum Zitat Goss B, Lutton C, Weinrauch P, Jabur M, Gillett G, Crawford R. Elution and mechanical properties of antifungal bone cement. J Arthroplasty. 2007;22:902–908.PubMedCrossRef Goss B, Lutton C, Weinrauch P, Jabur M, Gillett G, Crawford R. Elution and mechanical properties of antifungal bone cement. J Arthroplasty. 2007;22:902–908.PubMedCrossRef
6.
Zurück zum Zitat Grimsrud C, Raven R, Fothergill AW, Kim HT. The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute. Orthopedics. 2011;34:e378–381.PubMed Grimsrud C, Raven R, Fothergill AW, Kim HT. The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute. Orthopedics. 2011;34:e378–381.PubMed
7.
Zurück zum Zitat Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res. 2004;427:79–85.PubMedCrossRef Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res. 2004;427:79–85.PubMedCrossRef
8.
Zurück zum Zitat Harmsen S, McLaren AC, Pauken C, McLemore R. Amphotericin B is cytotoxic at locally delivered concentrations. Clin Orthop Relat Res. 2011;469:3016–3021.PubMedCrossRef Harmsen S, McLaren AC, Pauken C, McLemore R. Amphotericin B is cytotoxic at locally delivered concentrations. Clin Orthop Relat Res. 2011;469:3016–3021.PubMedCrossRef
9.
Zurück zum Zitat Kweon C, McLaren AC, Leon C, McLemore R. Amphotericin B delivery from bone cement increases with porosity but strength decreases. Clin Orthop Relat Res. 2011;469:3002–3007.PubMedCrossRef Kweon C, McLaren AC, Leon C, McLemore R. Amphotericin B delivery from bone cement increases with porosity but strength decreases. Clin Orthop Relat Res. 2011;469:3002–3007.PubMedCrossRef
10.
Zurück zum Zitat Marra F, Robbins GM, Masri BA, Duncan C, Wasan KM, Kwong EH, Jewesson PJ. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg. 2001;44:383–386.PubMed Marra F, Robbins GM, Masri BA, Duncan C, Wasan KM, Kwong EH, Jewesson PJ. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg. 2001;44:383–386.PubMed
11.
Zurück zum Zitat McLaren A, McLemore R, Gutierrez F, Martin M. Local antimicrobial treatment. In: Cierney G III, McLaren A, Wongworowat M, eds. Orthopaedic Knowledge Update: Musculoskeletal Infection. Rosemont, IL, USA: American Academy of Orthopaedic Surgeons; 2009:95–117 McLaren A, McLemore R, Gutierrez F, Martin M. Local antimicrobial treatment. In: Cierney G III, McLaren A, Wongworowat M, eds. Orthopaedic Knowledge Update: Musculoskeletal Infection. Rosemont, IL, USA: American Academy of Orthopaedic Surgeons; 2009:95–117
12.
Zurück zum Zitat McLaren A, Nugent M, Economopoulos K, Kaul H, Vernon B, McLemore R. Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity. Clin Orthop Relat Res. 2009;467:1693–1698.PubMedCrossRef McLaren A, Nugent M, Economopoulos K, Kaul H, Vernon B, McLemore R. Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity. Clin Orthop Relat Res. 2009;467:1693–1698.PubMedCrossRef
13.
Zurück zum Zitat Miller R, McLaren A, Leon C, McLemore R. Mixing method affects elution and strength of high dose ALBC. Clin Orthop Relat Res. 2012 May 3 [Epub ahead of print]. DOI: 10.1007/s11999-012-2351-2. Miller R, McLaren A, Leon C, McLemore R. Mixing method affects elution and strength of high dose ALBC. Clin Orthop Relat Res. 2012 May 3 [Epub ahead of print]. DOI: 10.​1007/​s11999-012-2351-2.
14.
Zurück zum Zitat Rouse MS, Heijink A, Steckelberg JM, Patel R. Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro? Clin Orthop Relat Res. 2011;469:1466–1469.PubMedCrossRef Rouse MS, Heijink A, Steckelberg JM, Patel R. Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro? Clin Orthop Relat Res. 2011;469:1466–1469.PubMedCrossRef
15.
Zurück zum Zitat Sealy PI, Nguyen C, Tucci M, Benghuzzi H, Cleary JD. Delivery of antifungal agents using bioactive and nonbioactive bone cements. Ann Pharmacother. 2009;43:1606–1615.PubMedCrossRef Sealy PI, Nguyen C, Tucci M, Benghuzzi H, Cleary JD. Delivery of antifungal agents using bioactive and nonbioactive bone cements. Ann Pharmacother. 2009;43:1606–1615.PubMedCrossRef
16.
Zurück zum Zitat Silverberg D, Kodali P, Dipersio J, Acus R, Askew M. In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement. Clin Orthop Relat Res. 2002;403:228–231.PubMedCrossRef Silverberg D, Kodali P, Dipersio J, Acus R, Askew M. In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement. Clin Orthop Relat Res. 2002;403:228–231.PubMedCrossRef
Metadaten
Titel
Voriconazole Is Delivered From Antifungal-Loaded Bone Cement
verfasst von
Ryan B. Miller, MD
Alex C. McLaren, MD
Christine Pauken, PhD
Henry D. Clarke, MD
Ryan McLemore, PhD
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 1/2013
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-012-2463-8

Weitere Artikel der Ausgabe 1/2013

Clinical Orthopaedics and Related Research® 1/2013 Zur Ausgabe

Symposium: Papers Presented at the Annual Meetings of the Knee Society

Failure of Irrigation and Débridement for Early Postoperative Periprosthetic Infection

Symposium: Papers Presented at the Annual Meetings of the Knee Society

Total Knee Arthroplasty With a Computer-navigated Saw: A Pilot Study

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.